Therapeutic options in advanced prostate cancer: Present and future
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-007-0021-9.pdf
Reference38 articles.
1. Yagoda A, Petrylak D: Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 1993, 71(Suppl):1098–1109.
2. Tannock IF, de Wit R, Berry WR, et al.: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004, 351:1502–1512.
3. Petrylak DP, Tangen CM, Hussain MH, et al.: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004, 351:1513–1520.
4. Klotz L: Combined androgen blockade: an update. Urol Clin North Am 2006, 33:161–166.
5. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists’ Collaborative Group. Lancet 2000, 355:1491–1498.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PLGA nanomedical consignation: A novel approach for the management of prostate cancer;International Journal of Pharmaceutics;2024-03
2. Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell;Molecular Biology Reports;2023-01-06
3. Apoptotic mechanism of lantadene A from Lantana camara leaves against prostatic cancer cells;Egyptian Journal of Chemistry;2021-08-04
4. Mesoporous silica MCM-41 and HMS as advanced drug delivery carriers for bicalutamide;Journal of Drug Delivery Science and Technology;2021-04
5. Development of Advanced Drug Delivery Systems with Bicalutamide Based on Mesoporous Silica Particles;CR ACAD BULG SCI;2019-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3